Quarterly report pursuant to Section 13 or 15(d)

REVENUE FROM CONTRACTS WITH CUSTOMERS

v3.10.0.1
REVENUE FROM CONTRACTS WITH CUSTOMERS
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
NOTE 4. REVENUE FROM CONTRACTS WITH CUSTOMERS

Change in Accounting Policy

 

The Company adopted ASU 2014-09, “Revenue from Contracts with Customers (Topic 606)”, on January 1, 2018, using the modified retrospective method applied to contracts that were not completed as of January 1, 2018. Refer to Note 2 – Summary of Significant Accounting Policies for additional information.

 

Disaggregation of Revenue from Contracts with Customers.

 

The following table disaggregates revenue by significant product type for the three and six months ended June 30, 2018:

 

   

Three months

ended

June 30,

2018

   

Six months

ended

June 30,

2018

 
Venodol sales   $ 2,232     $ 16,690  
Total revenue from customers   $ 2,232     $ 16,690  

 

There were no significant contract liabilities or transaction price allocations to any remaining performance obligations as of June 30, 2018.